Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Exogenous surfactant administration for the treatment of acute lung injury

Oral Presentation
Chairs: S. Piepenbrock (Hannover, Germany), K. Falke (Berlin, Germany)

Download all media

*Improved effect in vivo* of a lung surfactant extract by taking time-dependent aqueous swelling behaviour into account** M. Larsson, J. Haitsma, T. Nylander, K. Larsson, B. Lachmann, P. Wollmer (Lund, Sweden; Rotterdam, The Netherlands)
Therapeutic lavage with rSP-C surfactant restores oxygenation and improves histological outcome in a rat lung lavage model of acute lung injury L. Wollin, R. Beume, D. Haefner (Konstanz, Germany)
Exogenous surfactant administration in patients at high risk to develop ARDS after multiple trauma K. Raymondos, J. Braun, M. Martin, T. Schmudlach, M. Brandes, D. Korth, B. Hillmer, W. Bernhard, H. C. Pape, S. Piepenbrock (Hannover, Lubeck, Germany)
When to start surfactant therapy (ST-therapy) of acute lung injury? O. A. Rosenberg, A. E. Bautin, V. V. Osovskich, E. K. Tcybulkin, S. V. Gavrilin, V. V. Lichvancev, V. V. Erochin, I. A. Kozlov, A. A. Seiliev, V. A. Volchkov, D. A. Granov (Saint-Petersburg, Moscow, Russia)
The outcome of ARDS in children with a PaO₂/FiO₂ ratio <65 is not improved by either surfactant or rescue therapies (nitric oxide, high frequency ventilation, ECMO) J. C. Möller, M. Kohl, P. Schmidt, H. Schuhmacher, The ARDS/Surfactant-Study-Group (Lübeck, Germany)
The relation of interleukin-1β (Il-1β) and surfactant parameters in human premature neonates L. J. Zimmermann, D. J. Janssen, J. E. H. Bunt, S. R. Tati, D. J. Wattimena, W. A. Dik, M. A. Versnel, V. P. Carnielli (Rotterdam, The Netherlands; Padova, Italy)